Chandler Chicco wins health contracts with Amgen and Novo

NEW YORK: Chandler Chicco (CCA) has been named agency of record for

the multiple product lines of two top healthcare companies, Amgen and

Novo Nordisk.

Amgen, a leading biotechnology company, had previously used the firm on

a project basis. The company will continue to retain Golin/Harris for

its corporate PR. However, Ogilvy PR and Manning, Selvage & Lee, which

it had used for various products, will lose out.

'Having one agency gives us a chance to do branding across indications,'

said Jeff Richardson, Amgen's director of global PR. The account is

worth several million dollars.

One factor in CCA's favor was the assurance that Amgen would be working

directly and frequently with agency principals Gianfranco Chicco and

Robert Chandler.

Richardson said the fiercely competitive environment makes a strong PR

strategy vital to success. 'It's the old formula that if you want

awareness, you use advertising, and if you want education and

understanding, you use PR,' he said.

'We are going up against some very big companies that have more

resources than we do, like Johnson & Johnson,' Richardson continued.

'How do you gain awareness against a competitor 10 times your size?'

For Denmark-based Novo Nordisk, which primarily develops treatments for

diabetes, CCA will be responsible for strengthening patient and

professional relationships, and overseeing product launches. 'We are

launching six major diabetes drugs in the next two to three years,' said

Tim Slee, the company's international communications manager. 'That's a

heavy load.'

Novo Nordisk had retained GCI in London and is now trying to raise its

profile in the US.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in